Retatrutide is an investigational triple-agonist peptide that activates GLP-1, GIP, and glucagon receptors. It’s being studied primarily for weight loss and metabolic disease, as it helps reduce appetite, increase energy expenditure, improve insulin sensitivity, and promote significant fat loss.